We are live on ! Find out more
PPC

Park Place Capital Portfolio holdings

AUM $499M
1-Year Est. Return 14.38%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+14.38%
3 Year Est. Return
+49.65%
5 Year Est. Return
10 Year Est. Return
AUM
$354M
AUM Growth
-$1.83M
Cap. Flow
-$14.7M
Cap. Flow %
-4.16%
Top 10 Hldgs %
29.19%
Holding
1,043
New
39
Increased
227
Reduced
328
Closed
39
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBY icon
951
Best Buy
BBY
$16.9B
$1.8K ﹤0.01%
22
EQR icon
952
Equity Residential
EQR
$25B
$1.78K ﹤0.01%
27
FOXF icon
953
Fox Factory Holding Corp
FOXF
$790M
$1.74K ﹤0.01%
+16
New +$1.64K
KKR icon
954
KKR & Co
KKR
$92.8B
$1.74K ﹤0.01%
31
HELE icon
955
Helen of Troy
HELE
$672M
$1.73K ﹤0.01%
16
HIG icon
956
Hartford Financial Services
HIG
$39.6B
$1.73K ﹤0.01%
24
DLTR icon
957
Dollar Tree
DLTR
$24.9B
$1.72K ﹤0.01%
12
MKFG
958
DELISTED
Markforged Holding Corporation
MKFG
$1.71K ﹤0.01%
142
INDB icon
959
Independent Bank
INDB
$4B
$1.69K ﹤0.01%
38
CARR icon
960
Carrier Global
CARR
$52.7B
$1.69K ﹤0.01%
34
SU icon
961
Suncor Energy
SU
$72.5B
$1.67K ﹤0.01%
57
EIX icon
962
Edison International
EIX
$25.9B
$1.67K ﹤0.01%
+24
New +$1.69K
GGG icon
963
Graco
GGG
$13.4B
$1.64K ﹤0.01%
19
CE icon
964
Celanese
CE
$4.82B
$1.62K ﹤0.01%
14
NYT icon
965
New York Times
NYT
$10.5B
$1.61K ﹤0.01%
41
FOXA icon
966
Fox Class A
FOXA
$25.9B
$1.6K ﹤0.01%
+47
New +$1.54K
BMRN icon
967
BioMarin Pharmaceuticals
BMRN
$11.9B
$1.56K ﹤0.01%
18
CYRX icon
968
CryoPort
CYRX
$740M
$1.55K ﹤0.01%
90
STT icon
969
State Street
STT
$50.8B
$1.54K ﹤0.01%
21
BNY
970
Bank of New York Mellon
BNY
$108B
$1.51K ﹤0.01%
34
NBIX icon
971
Neurocrine Biosciences
NBIX
$16.2B
$1.51K ﹤0.01%
16
-705
-98% -$68.9K
OGN icon
972
Organon & Co
OGN
$3.56B
$1.46K ﹤0.01%
70
NEM icon
973
Newmont
NEM
$111B
$1.41K ﹤0.01%
33
-77
-70% -$3.5K
IFF icon
974
International Flavors & Fragrances
IFF
$21.6B
$1.35K ﹤0.01%
+17
New +$1.46K
CIG icon
975
CEMIG Preferred Shares
CIG
$6.12B
$1.34K ﹤0.01%
663

Similar funds

Park Place Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Park Place Capital held 1,043 positions worth $354M, down 0.51% from $356M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Park Place Capital withdrew a net $14.7M in Q2 2023, closing 39 positions and reducing 328 holdings. Its most notable exit was Revvity, an estimated $157K position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Park Place Capital opened a new position in iShares Intermediate Government/Credit Bond ETF worth $1.03M.

  • Park Place Capital's largest Q2 2023 buy was iShares Intermediate Government/Credit Bond ETF: 10,000 shares worth $1.03M.
  • Park Place Capital added most to iShares Core S&P Mid-Cap ETF in Q2 2023, an estimated $801K increase.
  • Park Place Capital's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $4.49M.
  • Park Place Capital fully exited Revvity in Q2 2023, selling an estimated $157K.
  • Park Place Capital's ten largest holdings make up 29% of its $354M portfolio in Q2 2023.
  • Park Place Capital opened 39 new positions and closed 39 in Q2 2023.
  • Park Place Capital's portfolio value fell 0.51% quarter-over-quarter to $354M.

Based on Park Place Capital's 13F filing for Q2 2023, filed 4 Aug 2023.